Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

Analysis of bone lesions on 68Ga-PSMA-11 PET/CT in a randomized controlled trial of men with biochemical recurrence of prostate cancer post prostatectomy

Ismaheel Lawal, Ashesh Jani, Omotayo Adediran, Charles Marcus, Joseph Shelton, Pretesh Patel, Subir Goyal, Olayinka Abiodun-Ojo, Bruce Hershatter, Bridget Fielder, Vishal Dhere, Mark Goodman, Raghuveer Halkar and David Schuster
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P968;
Ismaheel Lawal
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashesh Jani
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omotayo Adediran
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Marcus
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph Shelton
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pretesh Patel
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Subir Goyal
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olayinka Abiodun-Ojo
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Hershatter
2Emory
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bridget Fielder
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vishal Dhere
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Goodman
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raghuveer Halkar
3Emory University Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Schuster
1Emory University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Figures

  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Analysis of bone lesions on 68Ga-PSMA-11 PET/CT in a randomized controlled trial of men with biochemical recurrence of prostate cancer post prostatectomy
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Analysis of bone lesions on 68Ga-PSMA-11 PET/CT in a randomized controlled trial of men with biochemical recurrence of prostate cancer post prostatectomy
Ismaheel Lawal, Ashesh Jani, Omotayo Adediran, Charles Marcus, Joseph Shelton, Pretesh Patel, Subir Goyal, Olayinka Abiodun-Ojo, Bruce Hershatter, Bridget Fielder, Vishal Dhere, Mark Goodman, Raghuveer Halkar, David Schuster
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P968;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Analysis of bone lesions on 68Ga-PSMA-11 PET/CT in a randomized controlled trial of men with biochemical recurrence of prostate cancer post prostatectomy
Ismaheel Lawal, Ashesh Jani, Omotayo Adediran, Charles Marcus, Joseph Shelton, Pretesh Patel, Subir Goyal, Olayinka Abiodun-Ojo, Bruce Hershatter, Bridget Fielder, Vishal Dhere, Mark Goodman, Raghuveer Halkar, David Schuster
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P968;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Clinical Phenotype and Outcomes of mCRPC Patients Resistant to 225Ac-PSMA Radioligand Therapy: Analysis of the WARMTH Act Multinational Study
  • Is it feasible to perform radiopharmaceutical therapies in patients with dialyses: Experience from a comprehensive cancer center in Germany
  • Comparative whole-body multi-parametric [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 PET/CT: a randomised and prospective intra-individual comparison of tracer dynamics
Show more Oncology: Clinical Therapy & Diagnosis (includes Phase 2, Phase 3, post approval studies) - GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire